Search
01/03/2024
Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
Melé-Ninot, G, Curto-Barredo, L, Bonfill-Orti, M, Expósito-Serrano, V, Munera-Campos, M, Nart, IF, Loughlin, CRM, Gómez-Armayones, S, Spertino, J, Serra-Baldrich, E. Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024; 65(2)DOI:10.1111/ajd.14196. PMID:38058123. IF:1.800(Q3/6D).
01/03/2024
Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation
Cubiro, X, Garcia-Melendo, C, Morales-Munera, CE, Riera-Mestre, A, Torres-Iglesias, R, Villanueva, B, Puig, L, Baselga, E. Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation. Actas Dermo-Sifiliograficas. 2024; 115(3)DOI:10.1016/j.ad.2024.01.003. PMID:38185205. IF:(Q/D).
01/03/2024
Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study
Abarzua-Araya, A, Bañuls, J, Cabo, H, Carrera, C, Gamo, R, González, S, Jaimes, N, Navarrete-Dechent, C, Anker, JP, Roldán-Marín, R, Segura, S, Yelamos, O, Puig, S, Malvehy, J. Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study. Actas Dermo-Sifiliograficas. 2024; 115(3)DOI:10.1016/j.ad.2024.01.018. PMID:38244840. IF:(Q/D).
01/03/2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, JF, Tribó, MJ, Armario-Hita, JC, Calleja-Hernández, MA, Ortiz-Frutos, FJ, Poveda, JL, Shepherd, J, Serra-Baldrich, E. Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis. Jeadv Clinical Practice. 2024; 3(1)DOI:10.1002/jvc2.275. PMID:. IF:(Q/D).
01/03/2024
Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain
Vilarrasa, E, Molina-Leyva, A, Martín, V, Coak, E, Truman, I, Wallinger, H, Richardson, C, Martorell, A. Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain. Jeadv Clinical Practice. 2024; 3(1)DOI:10.1002/jvc2.237. PMID:. IF:(Q/D).
01/01/2024
[Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases
Vilarrasa, E, Nicolau, J, de la Cueva, P, Goday, A, Gallardo, F, Martorell-Calatayud, A, Carrascosa, JM. [Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases. Actas Dermo-Sifiliograficas. 2024; 115(1)DOI:10.1016/j.ad.2023.10.019. PMID:37918631. IF:(Q/D).
01/01/2024
Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping
Fernández-figueras, MT, Pérez-muñoz, N, Puig, L, Posada-caez, R, Victoria, RB, Henriquez, M, Musulen, E. Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.40172. PMID:38956962. IF:3.700(Q1/2D).
01/01/2024
SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE
Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londoño, A, Lebwohl, M, Nash, P. SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:. PMID:. IF:3.700(Q1/2D).